Antigen processing, where tumor-specific T-Cell responses begin

Journal of Immunotherapy

Volumn 14, Issue 3, 1993, Pages 202-208

  Bennink, Jack R ^a   Anderson, Robert ^a   Bacik, Igor ^a   Cox, Josephine ^a   Day, Patricia ^a   Deng, Yuping ^a   Lapham, Cheryl ^a   Link, Heidi ^a   Russ, Gustav ^a   Yewdell, Jonathan W ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Antigen processing; Cytotoxic T lymphocytes; Major histocompatibility complex class I molecule; Recombinant vaccinia virus

Indexed keywords

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; CELL SPECIFICITY; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN TRANSPORT; T LYMPHOCYTE ACTIVATION; VACCINIA VIRUS; VIRUS RECOMBINANT;

ANIMAL; ANTIBODY SPECIFICITY; ANTIGEN PRESENTATION; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, NEOPLASM; BIOLOGICAL TRANSPORT; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMAN; PEPTIDES; T-LYMPHOCYTES, SUPPRESSOR-EFFECTOR;

EID: 0027374733     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/00002371-199310000-00006     Document Type: Article

References (42)

1. Tevethia S, Tevethia M, Lewis A, Reddy V, Weissman SA. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). IX. Analysis of TrAg in mouse cells synthesizing truncated SV40 large T antigen. Virology 1983;128:319-30.
2. Zinkernagel RM, Doherty PC. MHC resisted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction, specificity, function, and responsiveness. Advances in Immunology 1979;27:52-180.
3. Gooding LR, O’Connell KA. Recognition by cytotoxic T lymphocytes of cells expressing fragments of the SV40 tumor antigen. J Immunol 1983;131:2580-6.
4. Bennink JR, Yewdell JW, Gerhard W. A viral polymerase involved in recognition of influenza virus-infected cells by a cytotoxic T-cell clone. Nature 1982;296:75-6.
5. Townsend ARM, Skehel JJ. Influenza A specific cytotoxic T-cell clones that do not recognize viral glycoproteins. Nature 1982;300:655-7.
6. Bennink JR, Yewdell JW, Smith GL, Moss B. Anti-influenza virus cytotoxic T lymphocytes recognize the three viral polymerases and a nonstructural protein: responsiveness to individual viral antigens is major histocompatibility complex controlled. J Virol 1987;61:1098-102.
7. Yewdell JW, Bennink JR, Mackett M, Lefrancois L, Lyles DS, Moss B. Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes. J Exp Med 1986;163:1529-38.
8. Townsend ARM, Bastin J, Gould K, Brownlee GG. Cytotoxic T lymphocytes recognize influenza hemagglutinin that lacks a signal sequence. Nature 1986;324:575-7.
9. Yewdell JW, Bennink JR, Hosaka Y. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science 1988;239:637-40.
10. Moore MW, Carbone FR, Bevan MJ. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988;54:777-85.
11. Townsend A, Bastin J, Gould K, et al. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med 1988;168:1211-224.
12. Van Pel A, Boon T. T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions: a hypothesis. Immu-nogenetics 1989;29:75-9.
13. Monaco JJ, McDevitt HO. The LMP antigens: a stable MHC-controlled multisubunit protein complex. Hum Immunol 1986;15:416-26.
14. Martinez CK, Monaco JJ. Homology of proteasome sub-units to a major histocompatibility complex-linked LMP gene. Nature 1991;353:664-7.
15. Falk K, Rötzschke O, Stevanovic S, Jung G, Rammensee H-G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991;351:290-6.
16. Townsend A, Elliot T, Cerundolo V, Foster L, Barber B, Tse A. Assembly of MHC class I molecules analyzed in vitro. Cell 1990;62:285-95.
17. Deverson E, Gow IR, Coadwell WJ, Monaco JJ, Butcher GW, Howard JC. MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters. Nature 1990;348:738-41.
18. Trowsdale J, Hanson I, Mockridge I, Beck S, Townsend A, Kelly A. Sequences encoded in the class II region of the MHC related to the “ABC” superfamily of transporters. Nature 1990;348:741-7.
19. Spies T, Bresnhan M, Bahram S, et al. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 1990;348:744-7.
20. Monaco JJ, Cho S, Attaya M. Transport protein genes in the murine MHC: possible implications for antigen processing. Science 1990;250:1723-6.
21. +cells. Cell 1992;71:1205-14.
22. Ljunggren H-G, Kärre K. Host resistance directed selectively against H-2 deficient lymphoma variants: analysis of the mechanism. J Exp Med 1985;162:1745-59.
23. DeMars R, Chang CC, Shaw S, Reitnauer PJ, Sondel PM. Homozygous deletions that simultaneously eliminate expression of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class I antigens. Hum Immunol 1984;11:77-97.
24. Yewdell JW, Esquivel F, Arnold D, Spies T, Eisenlohr LC, Bennink JR. Presentation of numerous viral peptides to mouse MHC class I restricted T lymphocytes is mediated by the human MHC encoded transporter or by a hybrid mouse-human transporter. J Exp Med 1993;177:1785-90.
25. Eisenlohr LC, Yewdell JW, Bennink JR. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J Exp Med 1992;175:481-7.
26. Sherman LA, Burke TA, Biggs JA. Extracellular processing of antigens that bind class I major histocompatibility molecules. J Exp Med 1992;175:1221-6.
27. Eisenlohr LC, Bacik I, Bennink JR, Bernstein K, Yewdell JW. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes. Cell 1992;71:963-72.
28. Henderson RA, Michel H, Sakaguchi K, et al. HLA-A2.1-associated peptides from a mutant line: a second pathway of antigen presentation. Science 1992;255:1264-6.
29. Wei ML, Cresswell P. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 1992;356:443-6.
30. Gammon MC, Bednarek MA, Biddison WE, et al. Endogenous loading of HLA-A2 molecules with an analog of the influenza virus matrix protein-derived peptide and its inhibition by an exogenous peptide antagonist. J Immunol 1992;148:7-12.
31. Esquivel F, Yewdell JW, Bennink JR. RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes. J Exp Med 1992;175:163-8.
32. Hosken NA, Bevan MJ. An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S. J Exp Med 1992;175:719-29.
33. Zweerink HJ, Gammon MC, Utz U, et al. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells. J Immunol 1993;150:1763-71.
34. Yewdell JW, Bennink JR. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. Science 1989;244:1072-5.
35. Lapham CK, Bacik I, Yewdell JW, Kane KP, Bennink JR. Class I molecules retained in the endoplasmic reticulum bind antigenic peptides. J Exp Med 1993;177:1633-41.
36. Cox JH, Yewdell JW, Eisenlohr LC, Johnson PR, Bennink JR. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Science 1990;247:715-8.
37. Nilsson T, Jackson M, Peterson PA. Short cytoplasmic sequences serve as retention signals for transmembrane proteins in the endoplasmic reticulum. Cell 1989;58:707-18.
38. Restifo NP, Esquivel F, Asher AL, et al. Defective presentation of endogenous antigens by a murine sarcoma: implications for the failure of an anti-tumor immune response. J Immunol 1991;147:1453-9.
39. Restifo NP, Esquivel F, Kawakami Y, et al. Identification of human cancers deficient in antigen processing. J Exp Med 1993;177:265-72.
40. Fearon ER, Pardoll DM, Itaya T, et al. Interleukin-2 production by tumor cells bypasses T helper function in the generation of a antitumor response. Cell 1990;60:397-403.
41. +T cells against the wild-type tumor: correlation with antigen presentation capability. J Exp Med 1992;175:1423.
42. +T cells by B7-transfected melanoma cells. Science 1993;259:368-70.